Literature DB >> 16002285

Synthesis and antiamoebic activity of new oxime ether derivatives containing 2-acetylpyridine/2-acetylfuran.

Mohammad Abid1, Kakul Husain, Amir Azam.   

Abstract

Various oxime ether derivatives of 2-acetylpyridine and 2-acetylfuran series have been synthesised. O-Alkylation of the oximes by various alkylaminoethyl halides gave the corresponding oxime ether derivatives. The structures of these compounds were elucidated by UV, IR, 1H NMR, 13C NMR spectroscopic methods and elemental analyses. All the compounds were screened in vitro against the HM1:IMSS strain of Entamoeba histolytica. Based on the 50% inhibitory concentration (IC50) data of the 12 compounds evaluated, two of the 2-acetylpyridine series and two in the 2-acetylfuran series showed better IC50 values in vitro when compared with the standard amoebicidal drug, metronidazole. Moreover, one compound showed the most promising antiamoebic activity (IC50=0.5 microM vs IC50=1.9 microM of metronidazole).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16002285     DOI: 10.1016/j.bmcl.2005.06.029

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  3 in total

1.  Study of the Room-Temperature Synthesis of Oxime Ethers by using a Super Base.

Authors:  Tomasz Kosmalski; Renata Studzińska; Natalia Daniszewska; Małgorzata Ullrich; Adam Sikora; Michał Marszałł; Bożena Modzelewska-Banachiewicz
Journal:  ChemistryOpen       Date:  2018-07-25       Impact factor: 2.911

2.  Naturally occurring sesquiterpene lactones and their semi-synthetic derivatives modulate PGE2 levels by decreasing COX2 activity and expression.

Authors:  Filomena Perri; Luca Frattaruolo; Ian Haworth; Matteo Brindisi; Asma El-magboub; Angela Ferrario; Charles Gomer; Francesca Aiello; James David Adams
Journal:  Heliyon       Date:  2019-03-27

3.  Novel alkylaminoethyl derivatives of androstane 3-oximes as anticancer candidates: synthesis and evaluation of cytotoxic effects.

Authors:  Jovana J Ajduković; Dimitar S Jakimov; Lucie Rárová; Miroslav Strnad; Yaraslau U Dzichenka; Sergey Usanov; Dušan Đ Škorić; Suzana S Jovanović-Šanta; Marija N Sakač
Journal:  RSC Adv       Date:  2021-11-22       Impact factor: 3.361

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.